Sort by
Refine Your Search
-
Country
-
Employer
- THE UNIVERSITY OF HONG KONG
- University of North Carolina at Chapel Hill
- CNRS
- Duke University
- King's College London
- Stanford University
- University of Maryland, Baltimore
- University of Oslo
- FAPESP - São Paulo Research Foundation
- HONG KONG BAPTIST UNIVERSITY
- Institut Pasteur
- Institute of Physical Chemistry, Polish Academy of Sciences
- SUNY University at Buffalo
- Saint Louis University
- University of California, Los Angeles
- University of Oxford
- University of Washington
- Yale University
- Aarhus University
- Baylor College of Medicine
- CIC bioGUNE
- Columbia Center for Translational Immunoogy
- Delaware State University
- EPFL
- Eli Lilly and Company
- Imperial College London
- Indiana University
- Institute of Macromolecular Chemistry CAS
- Johns Hopkins University
- Lunds universitet
- Rutgers University
- SciLifeLab
- St Jude Children's Research Hospital
- Texas A&M AgriLife
- The Ohio State University
- Umeå University
- Uniklinik Köln
- University of Colorado
- University of Copenhagen
- University of Lund
- University of Oxford;
- University of Texas at Dallas
- Wroclaw University of Science and Technology
- Zintellect
- 34 more »
- « less
-
Field
-
documentation of having received the Tdap (Tetanus, diphtheria, pertussis) vaccination. This may include documentation of having two (2) MMR vaccines; two (2) Varicella vaccines; or antibody status
-
to characterize peanut and tree nut allergens and the interactions between food allergens and antibodies that cause food allergies. You will be a part of a research team that conducts basic and applied research
-
on the human antibody and B cell response to H. Pylori infection and rational vaccine design of H. Pylori and malaria vaccines. Ideal candidates will be experienced in human and or mouse B cell biology and use
-
techniques such as cloning, PCR, mutagenesis, DNA extraction, gel electrophoresis 4. Knowledge of protein/antibody discovery and optimization using in vitro display (such as phage or yeast) technology 5
-
on vaccine responses will be assessed using the optimal mRNA-LNP formulation defined in Aim 1, with readouts focusing on specific B cell responses and antibody maturation. This project should provide a robust
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 2 months ago
and define mechanisms of tolerance-induction by antibody-based and microparticle-based antigen-specific immunotherapies for the prevention and reversal of T1D. The work is supported by numerous state
-
, tissues, and organs using antibody-based imaging, transcriptomics, and systems biology approaches. Since its launch, the atlas has generated one of the world’s most comprehensive open resources for spatial
-
understand the correlation between dengue vaccine protection and antibody enhancement. Unwanted/unsafe epitopes will be removed via viral engineering. Research skills in structural, engineering, and evolution
-
response. The Postdoctoral Associate will be responsible for: Designing antibody panels to examine the bladder innate immune response during various challenges, including bacterial infection. Participating
-
Technology Platform scientists. There will be opportunities to work across the group, from advanced organic synthesis, host-guest studies, peptide synthesis, antibody-drug conjugate design, and lipid